EU to Review Novo Nordisk’s Ozempic Over Eye Disease Concerns
The European Medicines Agency (EMA) announced it would evaluate two recent Danish studies linking Novo Nordisk’s diabetes medication, Ozempic, to an increased risk of a rare...
The European Medicines Agency (EMA) announced it would evaluate two recent Danish studies linking Novo Nordisk’s diabetes medication, Ozempic, to an increased risk of a rare...
The European Medicines Agency (EMA) announced it would evaluate two recent Danish studies linking Novo Nordisk’s diabetes medication, Ozempic, to an increased risk of a rare...
Startups from Japan and India have announced a partnership to explore the potential of using laser-equipped satellites to address the growing problem of space debris. The...